Augmedix, Inc. (NASDAQ:AUGX) Q4 2022 Earnings Call Transcript

Allen Klee: Thank you. Can I ask one other question, do you think that in €˜23 that gross margins have their potential to improve over €˜22?

Paul Ginocchio: Hey, Alan, it’s Paul. Good question. Absolutely. Obviously 2022 was impacted by the higher growth of our U.S. Service — excuse me, serviced operations, we’re not going to see that again in 2023. We may actually see U.S. Serviced clinicians go down as a percent of our mix. And so that will be a benefit to gross margins over time.

Allen Klee: Thank you so much.

Operator: Thank you. At this time, I’ll hand the floor back management for any further remarks.

Manny Krakaris: Well, we appreciate everybody coming online and listening to our earnings call and we’ll take callbacks later today and tomorrow with those that are interested in more in-depth questions-and-answers. Thank you all, and we’ll keep you posted on our progress.

Operator: Thank you. This will conclude today’s conference. You may disconnect your lines at this time. Thank you for your participation.